### **Overview** Sharda Cropchem Limited is a fast-growing, India-headquartered global player in the **generic crop protection chemicals** industry, with a strong and expanding presence in both **agrochemical and non-agrochemical sectors**. Founded in 1987, the company has evolved from its origins in dye intermediates to become a leading **IP-driven, asset-light** agrochemical marketer and distributor. It operates in over **80 countries** across Europe, North America (NAFTA), Latin America (LATAM), and the Rest of the World (RoW), positioning itself as a **one-stop solution provider** for global crop care needs. --- ### **Business Model: Asset-Light & IP-Driven** Sharda Cropchem follows a **differentiated asset-light business model**, avoiding capital-intensive manufacturing and R&D. Instead, it: - **Outsources manufacturing** of active ingredients (primarily from China and India) and formulation (from Europe and the U.S.). - Focuses internally on identifying **off-patent or near-expiry generic molecules**, preparing regulatory dossiers, and securing product registrations. - Leverages long-term partnerships with over **50 trusted third-party manufacturers and formulators**, ensuring quality, cost efficiency, and supply chain resilience. This model results in: - **Low capital intensity** and high capital efficiency. - Scalable operations with rapid market entry. - Strong gross margins and flexibility to adapt to fluctuating demand. - Enhanced operational agility, especially during economic downturns or supply volatility. --- ### **Core Business Segments** #### **1. Agrochemicals (Primary Revenue Generator)** A diversified portfolio of generic crop protection chemicals, including: - **Fungicides, Herbicides, Insecticides, and Biocides (including disinfectants)** - Products for **turf, specialty crops**, and agricultural biologicals (eco-friendly solutions) In **FY24–25**, agrochemicals contributed significantly to revenues amid a recovery from prior-year challenges. The segment is seasonal but shows strong resilience in key markets. #### **2. Non-Agrochemicals (Diversification Arm)** Provides revenue diversification through: - **Conveyor and V-belts** - **Industrial chemicals, dyes, and dye intermediates** - Sourced from Chinese and Indian manufacturers, distributed globally via existing logistics network This segment showed early signs of recovery in FY25 and is viewed as **strategically complementary**, helping hedge against agro-specific risks. --- ### **Global Operations & Market Presence** - **Geographic Footprint**: Active in **80+ countries**, with a strategic focus on **high-barrier, regulated markets** such as: - Europe - North America (U.S., Canada, Mexico) - Latin America (Colombia, Bolivia) - Africa and Southeast Asia - **Exports**: 100% of total turnover is export-oriented. - **Subsidiaries**: Global footprint supported by fully-owned subsidiaries including: - Sharda Europe BVBA (Belgium) - Sharda USA LLC - Sharda Mexico, Sharda Colombia S.A.S. - Sharda International Africa (PTY) Ltd, and others --- ### **Distribution & Sales Strategy: Factory-to-Farmer Model** Sharda Cropchem is executing a **forward-integrated “Factory-to-Farmer” strategy** to become a **comprehensive crop care solution provider**: - **Hybrid Distribution Network**: - **525+ third-party distributors** - **500+ direct sales professionals** across 80+ countries - **Expansion of in-house sales force** in high-potential markets: - Europe, USA, Canada, Mexico, Colombia, South Africa, India - This dual model allows: - Real-time market intelligence - Deeper customer engagement - Tailored solutions based on **local soil, weather, and crop conditions** - Higher control over branding, margins, and distribution --- ### **Product Registrations: Key Competitive Moat** Regulatory registrations form the **core of Sharda’s intellectual property (IP) and competitive advantage**: - As of **March 31, 2025**: - **2,964 approved product registrations** globally - **1,014 applications pending** across major jurisdictions - Focus on filing registrations **in its own name** to: - Gain operational autonomy - Improve margins - Respond faster to competition - Build a proprietary, scalable dossier library Registrations are concentrated in high-barrier markets, enabling economies of scale and reinforcing market leadership. --- ### **Sourcing & Supply Chain** - **Active Ingredients**: ~90–95% sourced from **China and India** - **Formulations**: Outsourced to specialized partners in **Europe and the U.S.** - **Benefits**: - Cost competitiveness, especially in price-sensitive markets - Multi-sourcing reduces supply chain risk - Partnerships ensure compliance with international quality standards - Strong working relationships with **GLP-certified labs** for dossier preparation --- ### **Financial Highlights (FY2024–2025)** - **Revenue**: ₹4,320 crores - **EBITDA**: ₹682 crores - **Revenue Growth**: 37% YoY — driven by agrochemical rebound and improved market alignment - **Capital Expenditure**: ₹420 crores in FY25 - Focused on **registration costs, digital integration, and sales force expansion** - Q1 FY26 CAPEX: ₹114 crores (targeted investments continuing) - **Balance Sheet**: **Zero debt**, strong cash position - **Divestment of Inventory Overhang and cost optimization** contributed to turnaround in FY25 --- ### **Strategic Imperatives & Growth Drivers** 1. **Expand Registration Portfolio**: - Target 100–150 new product launches annually from a pipeline of 150+ molecules. - Focus on high-potential, hard-to-enter generic molecules in regulated markets. 2. **Deepen Market Penetration & Geographic Expansion**: - Use dossier library to enter new markets and deepen presence in existing ones. - Focus on LATAM and emerging European markets. 3. **Operational Efficiency**: - Cost optimization, working capital discipline, and **digital integration** to maintain margins. - Eliminating non-value-adding processes. 4. **Biocides & Biologicals Focus**: - Strategic expansion into **biocides and agricultural biologicals**. - Aligns with global trend toward sustainable, eco-friendly farming. - Biocides currently marketed in 39+ countries, with projected market growth at 5–11% CAGR. 5. **Strengthen IP and Brand Equity**: - Growing dossier library supports innovation, compliance, and market access. - Customized packaging and formulations enhance brand trust and recall. --- ### **Management & Promoters** - **Mr. Ramprakash V. Bubna**: Founder, Chairman & MD (54+ years in chemicals & agrochemicals) - **Mrs. Sharda R. Bubna**: Founder, Whole-time Director - **Mr. Ashish R. Bubna**: Whole-time Director; led early dossier development and registration strategy Promoter group brings deep industry expertise, enabling strategic navigation of complex regulatory landscapes.